Literature DB >> 28244110

The P2X7 receptor links mechanical strain to cytokine IL-6 up-regulation and release in neurons and astrocytes.

Wennan Lu1, Farraj Albalawi1,2, Jonathan M Beckel1,3, Jason C Lim1, Alan M Laties4, Claire H Mitchell1,4,5.   

Abstract

Mechanical strain in neural tissues can lead to the up-regulation and release of multiple cytokines including interleukin 6 (IL-6). In the retina, the mechanosensitive release of ATP can autostimulate P2X7 receptors on both retinal ganglion cell neurons and optic nerve head astrocytes. Here, we asked whether the purinergic signaling contributed to the IL-6 response to increased intraocular pressure (IOP) in vivo, and stretch or swelling in vitro. Rat and mouse eyes were exposed to non-ischemic elevations in IOP to 50-60 mmHg for 4 h. A PCR array was used to screen cytokine changes, with quantitative (q)PCR used to confirm mRNA elevations and immunoblots used for protein levels. P2X7 antagonist Brilliant Blue G (BBG) and agonist (4-benzoyl-benzoyl)-ATP (BzATP) were injected intravitreally. ELISA was used to quantify IL-6 release from optic nerve head astrocytes or retinal ganglion cells. Receptor identity was confirmed pharmacologically and in P2X7-/- mice, acute elevation of IOP altered retinal expression of multiple cytokine genes. Elevation of IL-6 was greatest, with expression of IL1rn, IL24, Tnf, Csf1, and Lif also increased more than twofold, while expression of Tnfsf11, Gdf9, and Tnfsf4 were reduced. qPCR confirmed the rise in IL-6 and extracellular ATP marker ENTPD1, but not pro-apoptotic genes. Intravitreal injection of P2X7 receptor antagonist BBG prevented the pressure-dependent rise in IL-6 mRNA and protein in the rat retina, while injection of P2X7 receptor agonist BzATP was sufficient to elevate IL-6 expression. IOP elevation increased IL-6 in wild-type but not P2X7R knockout mice. Application of mechanical strain to isolated optic nerve head astrocytes increased IL-6 levels. This response was mimicked by agonist BzATP, but blocked by antagonists BBG and A839977. Stretch or BzATP led to IL-6 release from both astrocytes and isolated retinal ganglion cells. The mechanosensitive up-regulation and release of cytokine IL-6 from the retina involves the P2X7 receptor, with both astrocytes and neurons contributing to the response.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  zzm321990IOPzzm321990; P2X7; astrocytes; cytokines; mechanical strain; retina

Mesh:

Substances:

Year:  2017        PMID: 28244110      PMCID: PMC5408351          DOI: 10.1111/jnc.13998

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  61 in total

1.  Balance of purines may determine life or death of retinal ganglion cells as A3 adenosine receptors prevent loss following P2X7 receptor stimulation.

Authors:  Xiulan Zhang; Mei Zhang; Alan M Laties; Claire H Mitchell
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

2.  Interleukin-6 protects retinal ganglion cells from pressure-induced death.

Authors:  Rebecca M Sappington; Matilda Chan; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-07       Impact factor: 4.799

3.  Sustained elevation of extracellular ATP in aqueous humor from humans with primary chronic angle-closure glaucoma.

Authors:  Ang Li; Xiulan Zhang; Danying Zheng; Jian Ge; Alan M Laties; Claire H Mitchell
Journal:  Exp Eye Res       Date:  2011-07-02       Impact factor: 3.467

4.  Neurons respond directly to mechanical deformation with pannexin-mediated ATP release and autostimulation of P2X7 receptors.

Authors:  Jingsheng Xia; Jason C Lim; Wennan Lu; Jonathan M Beckel; Edward J Macarak; Alan M Laties; Claire H Mitchell
Journal:  J Physiol       Date:  2012-03-12       Impact factor: 5.182

Review 5.  The P2X7 receptor: a key player in IL-1 processing and release.

Authors:  Davide Ferrari; Cinzia Pizzirani; Elena Adinolfi; Roberto M Lemoli; Antonio Curti; Marco Idzko; Elisabeth Panther; Francesco Di Virgilio
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

6.  P2X7-dependent, but differentially regulated release of IL-6, CCL2, and TNF-α in cultured mouse microglia.

Authors:  Chu-Hsin Shieh; Annette Heinrich; Tsvetan Serchov; Dietrich van Calker; Knut Biber
Journal:  Glia       Date:  2014-01-28       Impact factor: 7.452

7.  Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions.

Authors:  Scott S Wildman; Robert J Unwin; Brian F King
Journal:  Br J Pharmacol       Date:  2003-10-27       Impact factor: 8.739

8.  ATP release from non-excitable cells.

Authors:  Helle A Praetorius; Jens Leipziger
Journal:  Purinergic Signal       Date:  2009-03-20       Impact factor: 3.765

Review 9.  Interleukin-6, a major cytokine in the central nervous system.

Authors:  María Erta; Albert Quintana; Juan Hidalgo
Journal:  Int J Biol Sci       Date:  2012-10-25       Impact factor: 6.580

10.  ATP release and purinergic signaling in NLRP3 inflammasome activation.

Authors:  Aurélie Gombault; Ludivine Baron; Isabelle Couillin
Journal:  Front Immunol       Date:  2013-01-08       Impact factor: 7.561

View more
  18 in total

Review 1.  Purinergic signaling in the retina: From development to disease.

Authors:  Ana Lucia Marques Ventura; Alexandre Dos Santos-Rodrigues; Claire H Mitchell; Maria Paula Faillace
Journal:  Brain Res Bull       Date:  2018-11-17       Impact factor: 4.077

2.  Spinal P2X7R contributes to streptozotocin-induced mechanical allodynia in mice.

Authors:  Cheng-Ming Ni; He-Ping Sun; Xiang Xu; Bing-Yu Ling; Hui Jin; Yu-Qiu Zhang; Zhi-Qi Zhao; Hong Cao; Lan Xu
Journal:  J Zhejiang Univ Sci B       Date:  2020-02-14       Impact factor: 3.066

3.  Oral administration of the iron chelator deferiprone protects against loss of retinal ganglion cells in a mouse model of glaucoma.

Authors:  Qi N Cui; Albert R Bargoud; Ahmara G Ross; Ying Song; Joshua L Dunaief
Journal:  Exp Eye Res       Date:  2020-02-08       Impact factor: 3.467

4.  Reactive oxygen species play a role in P2X7 receptor-mediated IL-6 production in spinal astrocytes.

Authors:  Frances M Munoz; Priya A Patel; Xinghua Gao; Yixiao Mei; Jingsheng Xia; Sofia Gilels; Huijuan Hu
Journal:  Purinergic Signal       Date:  2020-03-07       Impact factor: 3.765

Review 5.  Targeting Neuroinflammation via Purinergic P2 Receptors for Disease Modification in Drug-Refractory Epilepsy.

Authors:  Tobias Engel; Jonathon Smith; Mariana Alves
Journal:  J Inflamm Res       Date:  2021-07-18

6.  The P2X7 Receptor Primes IL-1β and the NLRP3 Inflammasome in Astrocytes Exposed to Mechanical Strain.

Authors:  Farraj Albalawi; Wennan Lu; Jonathan M Beckel; Jason C Lim; Stuart A McCaughey; Claire H Mitchell
Journal:  Front Cell Neurosci       Date:  2017-08-08       Impact factor: 5.505

Review 7.  Novel Therapeutics in Glaucoma Management.

Authors:  Claudio Bucolo; Chiara Bianca Maria Platania; Filippo Drago; Vincenza Bonfiglio; Michele Reibaldi; Teresio Avitabile; Maurizio Uva
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

8.  High glucose inhibits osteogenic differentiation and proliferation of MC3T3‑E1 cells by regulating P2X7.

Authors:  Jinsan Yang; Cao Ma; Maoshu Zhang
Journal:  Mol Med Rep       Date:  2019-10-31       Impact factor: 2.952

9.  The P2Y12 Receptor Antagonist Ticagrelor Reduces Lysosomal pH and Autofluorescence in Retinal Pigmented Epithelial Cells From the ABCA4-/- Mouse Model of Retinal Degeneration.

Authors:  Wennan Lu; Néstor M Gómez; Jason C Lim; Sonia Guha; Ann O'Brien-Jenkins; Erin E Coffey; Keith E Campagno; Stuart A McCaughey; Alan M Laties; Leif G Carlsson; Claire H Mitchell
Journal:  Front Pharmacol       Date:  2018-04-19       Impact factor: 5.810

Review 10.  Purinergic Receptors in Neurological Diseases With Motor Symptoms: Targets for Therapy.

Authors:  Ágatha Oliveira-Giacomelli; Yahaira Naaldijk; Laura Sardá-Arroyo; Maria C B Gonçalves; Juliana Corrêa-Velloso; Micheli M Pillat; Héllio D N de Souza; Henning Ulrich
Journal:  Front Pharmacol       Date:  2018-04-10       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.